biote Balance Sheet Health

Financial Health criteria checks 2/6

biote has a total shareholder equity of $-126.8M and total debt of $118.8M, which brings its debt-to-equity ratio to -93.7%. Its total assets and total liabilities are $101.3M and $228.1M respectively. biote's EBIT is $39.9M making its interest coverage ratio 4.3. It has cash and short-term investments of $38.2M.

Key information

-93.7%

Debt to equity ratio

US$118.80m

Debt

Interest coverage ratio4.3x
CashUS$38.23m
Equity-US$126.82m
Total liabilitiesUS$228.08m
Total assetsUS$101.25m

Recent financial health updates

Recent updates

Market Cool On biote Corp.'s (NASDAQ:BTMD) Revenues

Sep 27
Market Cool On biote Corp.'s (NASDAQ:BTMD) Revenues

biote initiated as a buy at Truist on leadership in hormone optimization; sees 138% upside

Sep 27

Biote partners with IMAC Holdings

Sep 07

Financial Position Analysis

Short Term Liabilities: BTMD has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: BTMD has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: BTMD has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: BTMD's has negative shareholder equity, so we do not need to check if its debt has reduced over time.

Debt Coverage: BTMD's debt is well covered by operating cash flow (33.5%).

Interest Coverage: BTMD's interest payments on its debt are well covered by EBIT (4.3x coverage).


Balance Sheet


Discover healthy companies